Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology
Capsaicin has long been used as a traditional medicine to treat pain and, recently, its mechanism of analgesic action has been discovered. This review article documents the clinical development of capsaicin to demonstrate that pharmacognosy still has a profound influence on modern-day drug developme...
Gespeichert in:
Veröffentlicht in: | European neurology 2012-01, Vol.68 (5), p.264-275 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 275 |
---|---|
container_issue | 5 |
container_start_page | 264 |
container_title | European neurology |
container_volume | 68 |
creator | Haanpää, Maija Treede, Rolf-Detlef |
description | Capsaicin has long been used as a traditional medicine to treat pain and, recently, its mechanism of analgesic action has been discovered. This review article documents the clinical development of capsaicin to demonstrate that pharmacognosy still has a profound influence on modern-day drug development programs. Capsaicin is a highly selective agonist for the transient receptor potential channel vanilloid-receptor type 1 (TRPV1), which is expressed on central and peripheral terminals of nociceptive primary sensory neurons. Knockout studies have revealed the importance of TRPV1 as a molecular pain integrator and target for novel analgesic agents. Topical application of capsaicin at the peripheral terminal of TRPV1-expressing neurons superficially denervates the epidermis in humans in a highly selective manner and results in hypoalgesia. In three recent randomized controlled trials, a patch containing high-concentration capsaicin demonstrated meaningful efficacy and tolerability relative to a low-concentration capsaicin control patch in patients with peripheral neuropathic pain. Data from clinical practice will determine if the high-concentration capsaicin patch is effective in real-world settings. |
doi_str_mv | 10.1159/000339944 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_23037991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2900906381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-6cb37f89d236dcfad4eedfe3d0c6a25786dad4aef8fa26f630a532c066c91ab63</originalsourceid><addsrcrecordid>eNqF0TlPwzAYBmALgWg5BnaELLHAEPCRODEbVFxSOYTKHH31UQxpXOxm6L_HVUsHFibL1vO9lv0idETJBaWFvCSEcC5lnm-hPs0ZzaSkfBv1CaF5xgljPbQX42faFrKsdlGPccLLhProbQCzCE65Flsf8LPpgp_B_MMp_AquvcJD1365doJHAbSbO99Cg5-MXk4YDK3GT74xqmsg4BvnGz9ZHKAdC000h-t1H73f3Y4GD9nw5f5xcD3MVC6qeSbUmJe2kppxoZUFnRujreGaKAGsKCuh0xkYW1lgwgpOoOBMESGUpDAWfB-drXJnwX93Js7rqYvKNA20xnexpimk5CxPn_M_ZaQomSQy0dM_9NN3Ib06KU4ZZ5zK5d3nK6WCjzEYW8-Cm0JY1JTUy07qTSfJnqwTu_HU6I38LSGB4xX4gjAxYQPW8z_GKY5t</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1312323196</pqid></control><display><type>article</type><title>Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology</title><source>MEDLINE</source><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Haanpää, Maija ; Treede, Rolf-Detlef</creator><creatorcontrib>Haanpää, Maija ; Treede, Rolf-Detlef</creatorcontrib><description>Capsaicin has long been used as a traditional medicine to treat pain and, recently, its mechanism of analgesic action has been discovered. This review article documents the clinical development of capsaicin to demonstrate that pharmacognosy still has a profound influence on modern-day drug development programs. Capsaicin is a highly selective agonist for the transient receptor potential channel vanilloid-receptor type 1 (TRPV1), which is expressed on central and peripheral terminals of nociceptive primary sensory neurons. Knockout studies have revealed the importance of TRPV1 as a molecular pain integrator and target for novel analgesic agents. Topical application of capsaicin at the peripheral terminal of TRPV1-expressing neurons superficially denervates the epidermis in humans in a highly selective manner and results in hypoalgesia. In three recent randomized controlled trials, a patch containing high-concentration capsaicin demonstrated meaningful efficacy and tolerability relative to a low-concentration capsaicin control patch in patients with peripheral neuropathic pain. Data from clinical practice will determine if the high-concentration capsaicin patch is effective in real-world settings.</description><identifier>ISSN: 0014-3022</identifier><identifier>EISSN: 1421-9913</identifier><identifier>DOI: 10.1159/000339944</identifier><identifier>PMID: 23037991</identifier><identifier>CODEN: EUNEAP</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Analgesics ; Analgesics - therapeutic use ; Animals ; Capsaicin ; Capsaicin - therapeutic use ; Capsaicin receptors ; Clinical trials ; Data processing ; Drug development ; Epidermis ; Humans ; Medicine, Traditional ; Neuralgia - drug therapy ; Neuralgia - metabolism ; Neuropathy ; Pain perception ; Review ; Reviews ; Sensory neurons ; Topical application ; transient receptor potential proteins ; TRPV Cation Channels - agonists</subject><ispartof>European neurology, 2012-01, Vol.68 (5), p.264-275</ispartof><rights>2012 S. Karger AG, Basel</rights><rights>Copyright © 2012 S. Karger AG, Basel.</rights><rights>Copyright (c) 2012 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-6cb37f89d236dcfad4eedfe3d0c6a25786dad4aef8fa26f630a532c066c91ab63</citedby><cites>FETCH-LOGICAL-c468t-6cb37f89d236dcfad4eedfe3d0c6a25786dad4aef8fa26f630a532c066c91ab63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23037991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haanpää, Maija</creatorcontrib><creatorcontrib>Treede, Rolf-Detlef</creatorcontrib><title>Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology</title><title>European neurology</title><addtitle>Eur Neurol</addtitle><description>Capsaicin has long been used as a traditional medicine to treat pain and, recently, its mechanism of analgesic action has been discovered. This review article documents the clinical development of capsaicin to demonstrate that pharmacognosy still has a profound influence on modern-day drug development programs. Capsaicin is a highly selective agonist for the transient receptor potential channel vanilloid-receptor type 1 (TRPV1), which is expressed on central and peripheral terminals of nociceptive primary sensory neurons. Knockout studies have revealed the importance of TRPV1 as a molecular pain integrator and target for novel analgesic agents. Topical application of capsaicin at the peripheral terminal of TRPV1-expressing neurons superficially denervates the epidermis in humans in a highly selective manner and results in hypoalgesia. In three recent randomized controlled trials, a patch containing high-concentration capsaicin demonstrated meaningful efficacy and tolerability relative to a low-concentration capsaicin control patch in patients with peripheral neuropathic pain. Data from clinical practice will determine if the high-concentration capsaicin patch is effective in real-world settings.</description><subject>Analgesics</subject><subject>Analgesics - therapeutic use</subject><subject>Animals</subject><subject>Capsaicin</subject><subject>Capsaicin - therapeutic use</subject><subject>Capsaicin receptors</subject><subject>Clinical trials</subject><subject>Data processing</subject><subject>Drug development</subject><subject>Epidermis</subject><subject>Humans</subject><subject>Medicine, Traditional</subject><subject>Neuralgia - drug therapy</subject><subject>Neuralgia - metabolism</subject><subject>Neuropathy</subject><subject>Pain perception</subject><subject>Review</subject><subject>Reviews</subject><subject>Sensory neurons</subject><subject>Topical application</subject><subject>transient receptor potential proteins</subject><subject>TRPV Cation Channels - agonists</subject><issn>0014-3022</issn><issn>1421-9913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0TlPwzAYBmALgWg5BnaELLHAEPCRODEbVFxSOYTKHH31UQxpXOxm6L_HVUsHFibL1vO9lv0idETJBaWFvCSEcC5lnm-hPs0ZzaSkfBv1CaF5xgljPbQX42faFrKsdlGPccLLhProbQCzCE65Flsf8LPpgp_B_MMp_AquvcJD1365doJHAbSbO99Cg5-MXk4YDK3GT74xqmsg4BvnGz9ZHKAdC000h-t1H73f3Y4GD9nw5f5xcD3MVC6qeSbUmJe2kppxoZUFnRujreGaKAGsKCuh0xkYW1lgwgpOoOBMESGUpDAWfB-drXJnwX93Js7rqYvKNA20xnexpimk5CxPn_M_ZaQomSQy0dM_9NN3Ib06KU4ZZ5zK5d3nK6WCjzEYW8-Cm0JY1JTUy07qTSfJnqwTu_HU6I38LSGB4xX4gjAxYQPW8z_GKY5t</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Haanpää, Maija</creator><creator>Treede, Rolf-Detlef</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20120101</creationdate><title>Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology</title><author>Haanpää, Maija ; Treede, Rolf-Detlef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-6cb37f89d236dcfad4eedfe3d0c6a25786dad4aef8fa26f630a532c066c91ab63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analgesics</topic><topic>Analgesics - therapeutic use</topic><topic>Animals</topic><topic>Capsaicin</topic><topic>Capsaicin - therapeutic use</topic><topic>Capsaicin receptors</topic><topic>Clinical trials</topic><topic>Data processing</topic><topic>Drug development</topic><topic>Epidermis</topic><topic>Humans</topic><topic>Medicine, Traditional</topic><topic>Neuralgia - drug therapy</topic><topic>Neuralgia - metabolism</topic><topic>Neuropathy</topic><topic>Pain perception</topic><topic>Review</topic><topic>Reviews</topic><topic>Sensory neurons</topic><topic>Topical application</topic><topic>transient receptor potential proteins</topic><topic>TRPV Cation Channels - agonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haanpää, Maija</creatorcontrib><creatorcontrib>Treede, Rolf-Detlef</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>European neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haanpää, Maija</au><au>Treede, Rolf-Detlef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology</atitle><jtitle>European neurology</jtitle><addtitle>Eur Neurol</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>68</volume><issue>5</issue><spage>264</spage><epage>275</epage><pages>264-275</pages><issn>0014-3022</issn><eissn>1421-9913</eissn><coden>EUNEAP</coden><abstract>Capsaicin has long been used as a traditional medicine to treat pain and, recently, its mechanism of analgesic action has been discovered. This review article documents the clinical development of capsaicin to demonstrate that pharmacognosy still has a profound influence on modern-day drug development programs. Capsaicin is a highly selective agonist for the transient receptor potential channel vanilloid-receptor type 1 (TRPV1), which is expressed on central and peripheral terminals of nociceptive primary sensory neurons. Knockout studies have revealed the importance of TRPV1 as a molecular pain integrator and target for novel analgesic agents. Topical application of capsaicin at the peripheral terminal of TRPV1-expressing neurons superficially denervates the epidermis in humans in a highly selective manner and results in hypoalgesia. In three recent randomized controlled trials, a patch containing high-concentration capsaicin demonstrated meaningful efficacy and tolerability relative to a low-concentration capsaicin control patch in patients with peripheral neuropathic pain. Data from clinical practice will determine if the high-concentration capsaicin patch is effective in real-world settings.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>23037991</pmid><doi>10.1159/000339944</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-3022 |
ispartof | European neurology, 2012-01, Vol.68 (5), p.264-275 |
issn | 0014-3022 1421-9913 |
language | eng |
recordid | cdi_pubmed_primary_23037991 |
source | MEDLINE; Karger Journals Complete; Alma/SFX Local Collection |
subjects | Analgesics Analgesics - therapeutic use Animals Capsaicin Capsaicin - therapeutic use Capsaicin receptors Clinical trials Data processing Drug development Epidermis Humans Medicine, Traditional Neuralgia - drug therapy Neuralgia - metabolism Neuropathy Pain perception Review Reviews Sensory neurons Topical application transient receptor potential proteins TRPV Cation Channels - agonists |
title | Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T17%3A48%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Capsaicin%20for%20Neuropathic%20Pain:%20Linking%20Traditional%20Medicine%20and%20Molecular%20Biology&rft.jtitle=European%20neurology&rft.au=Haanp%C3%A4%C3%A4,%20Maija&rft.date=2012-01-01&rft.volume=68&rft.issue=5&rft.spage=264&rft.epage=275&rft.pages=264-275&rft.issn=0014-3022&rft.eissn=1421-9913&rft.coden=EUNEAP&rft_id=info:doi/10.1159/000339944&rft_dat=%3Cproquest_pubme%3E2900906381%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1312323196&rft_id=info:pmid/23037991&rfr_iscdi=true |